Reference health
Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders
74/74 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 74 checked references that resolve
resolves10.1001/jamanetworkopen.2018.7621
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
resolves10.1016/j.jpain.2016.02.015
Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System
resolves10.1016/j.drugalcdep.2014.06.005
Factors contributing to the rise of buprenorphine misuse: 2008–2013
resolves10.1016/j.neuropharm.2019.06.001
Development of vaccines to treat opioid use disorders and reduce incidence of overdose
resolves10.1080/14760584.2017.1378577
Current status and future prospects for the development of substance abuse vaccines
resolves10.1124/jpet.112.201194
Selective Effects of a Morphine Conjugate Vaccine on Heroin and Metabolite Distribution and Heroin-Induced Behaviors in Rats
resolves10.1124/jpet.118.253674
A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats
resolves10.1021/acs.molpharmaceut.8b00592
Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins
resolves10.1124/jpet.117.247049
Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats
resolves10.1371/journal.pone.0101807
Effects of an Oxycodone Conjugate Vaccine on Oxycodone Self-Administration and Oxycodone-Induced Brain Gene Expression in Rats
resolves10.1016/j.neuropharm.2018.06.026
Prophylactic vaccination protects against the development of oxycodone self-administration
resolves10.1021/acs.jmedchem.7b01427
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse
resolves10.1038/clpt.2010.317
Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine Immunotherapeutic
resolves10.1001/archgenpsychiatry.2009.128
Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained Patients
resolves10.4049/jimmunol.1500385
The Frequency of Naive and Early-Activated Hapten-Specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse
resolves10.1016/j.vaccine.2015.09.015
The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence
resolves10.3389/fimmu.2018.00348
T Cell Subsets in the Germinal Center: Lessons from the Macaque Model
resolves10.1039/C7CC04055E
A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior
resolves10.1021/acs.molpharmaceut.7b00933
Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality
resolves10.1021/mp400631w
Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy
resolves10.1080/21645515.2018.1558697
Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders
resolves10.1371/journal.pone.0096547
Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats
resolves10.1046/j.1365-2249.2002.01973.x
Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma
resolves10.1111/bcp.13748
Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study
resolves10.1111/j.1749-6632.2009.04939.x
Clinical Use of Anti‐CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
resolves10.1038/s41598-019-49485-3
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
resolves10.1136/lupus-2016-000146
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus
resolves10.1038/s41598-018-23777-6
Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose
resolves10.3389/fimmu.2018.00888
Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
resolves10.4049/jimmunol.1500497
Nonredundant Roles of IL-21 and IL-4 in the Phased Initiation of Germinal Center B Cells and Subsequent Self-Renewal Transitions
resolves10.1002/eji.201444825
Cognate interactions: Extrafollicular IL‐4 drives germinal‐center reactions, a new role for an old cytokine
resolves10.1002/eji.201344203
<scp>B</scp>‐cell‐intrinsic <scp>STAT</scp>6 signaling controls germinal center formation
resolves10.1111/j.1365-3083.1989.tb01221.x
Regulation of IgG1 and IgE Synthesis by Interleukin 4 in Mouse B Cells
resolves10.1016/j.cyto.2015.05.010
T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production
resolves10.1016/j.cell.2017.11.036
Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells
resolves10.1038/ni.3554
TFH cells progressively differentiate to regulate the germinal center response
resolves10.4049/jimmunol.159.8.3757
The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells
resolves10.1128/IAI.69.1.228-236.2001
Signaling via Interleukin-4 Receptor α Chain Is Required for Successful Vaccination against Schistosomiasis in BALB/c Mice
resolves10.1016/S0165-2478(00)00202-9
Absence of interleukin-4 enhances germinal center reaction in secondary immune response
resolves10.1016/j.vaccine.2014.08.023
Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy
resolves10.1016/j.vaccine.2006.07.024
Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response
resolves10.1371/journal.pone.0184876
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse
resolves10.4049/jimmunol.1402604
Oil-in-Water Emulsion MF59 Increases Germinal Center B Cell Differentiation and Persistence in Response to Vaccination
resolves10.1172/JCI117546
Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.
resolves10.1128/IAI.73.11.7620-7628.2005
Interleukin-4 (IL-4) and IL-10 Collude in Vaccine Failure for Novel Exacerbatory Antigens in Murine
<i>Leishmania major</i>
Infection
resolves10.1093/infdis/jiu668
Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression
resolves10.4049/jimmunol.162.12.7302
Differences Between IL-4- and IL-4 Receptor α-Deficient Mice in Chronic Leishmaniasis Reveal a Protective Role for IL-13 Receptor Signaling
resolves10.4049/jimmunol.157.11.4926
IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway
resolves10.1084/jem.186.2.325
Interleukin 4 (IL-4) or IL-7 Prevents the Death of Resting T Cells: Stat6 Is Probably Not Required for the Effect of IL-4
resolves10.1016/B978-0-12-800100-4.00001-5
Multifarious Determinants of Cytokine Receptor Signaling Specificity
resolves10.1074/jbc.273.47.31222
The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common γ-Chain
resolves10.3389/fimmu.2018.00716
The Hunt for the Source of Primary Interleukin-4: How We Discovered That Natural Killer T Cells and Basophils Determine T Helper Type 2 Cell Differentiation In Vivo
resolves10.1034/j.1600-065X.2001.1800101.x
The role of complement in inflammation and adaptive immunity
resolves10.1016/j.immuni.2008.02.001
Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells
resolves10.1016/j.immuni.2013.10.018
Intracellular Complement Activation Sustains T Cell Homeostasis and Mediates Effector Differentiation
resolves10.1128/JVI.02128-06
Natural Antibody and Complement Mediate Neutralization of Influenza Virus in the Absence of Prior Immunity
resolves10.1128/jvi.76.5.2150-2158.2002
Complement-Mediated Enhancement of Antibody Function for Neutralization of Pseudotype Virus Containing Hepatitis C Virus E2 Chimeric Glycoprotein
resolves10.1016/j.vaccine.2008.05.011
Gender-specific effects of cytokine gene polymorphisms on childhood vaccine responses
The 5 references without a DOI — listed, not checked
no DOI — not checkedWorld Health Organization. Information Sheet on Opioid Overdose [cited]. https://www.who.int/substance_abuse/information-sheet/en/ (2018).
no DOI — not checkedHoward, J., Cimineri, L., Evans, T., Chosewood, L. C. & Afanuh, S. Medication-assisted Treatment For Opioid Use Disorder. (USDHHS, CDC and NIOSH, 2019).
no DOI — not checkedAdministration, S.A.A.M.H.S. MAT Statutes, Regulations, and Guidelines [cited]. https://www.samhsa.gov/medication-assisted-treatment/statutes-regulations-guidelines (2019).
no DOI — not checkedWang, N., Liang, H. & Zen, K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol. 5, 614 (2014).
no DOI — not checkedJassal, B. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 48, D498–D503 (2020).
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1038/s41541-020-00247-7"><img src="https://citestamp.com/citestamped/10.1038/s41541-020-00247-7/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1038/s41541-020-00247-7)